The cannabis legalization movement is expanding with Mexico now set to adopt a law making it legal for medical and scientific purposes.
On April 28, the Lower House of Congress approved a previously voted bill, according to the Yucatan Times, and will now go to the hands of Mexican president Enrique Peña Nieto for approval. According to Reuters, he is expected to sign it into law.
Despite the excitement surround the news, experts have said to lower expectations when it comes to drug trafficking in Mexico since the bill only refers to medical and scientific use.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

“It won’t change anything,” Raúl Benítez Manau, an expert on security affairs at the National Autonomous University of Mexico told the AFP. “Narcotrafficking is going to stay the same.”
Mexican officials will now have to begin drafting specific instructions for medical companies to follow as they begin using cannabis in their research.

Interest from Canada

Thanks to this announcement, Aaron Salz, an advisor for Canadian companies in the cannabis sector with Stoic Advisory, said in an interview with the Investing News Network it’s now likely for some types of partnerships to develop.
“I think you will definitely see interest in Canadian companies in participating in the Mexican market,” he said. “You will definitely see interest in companies right away in exporting to the Mexican market and to aiding those companies there in getting things set up.”
However, Salz also said he doesn’t think any companies will be rushing to set up shop in Mexico, due to an uncertainty in what the licensing process may look like there.
“You’ll certainly see partnerships, you’ll see information sharing. I would almost be certain that the regulators will communicate with each other if they haven’t already,” Salz added.
Salz told the Investing News Network one of the most exciting things in the cannabis sector right now is that Canadian companies can be part of the export process for medical purposes in countries like Brazil, Australia, and Germany.
As of yet, no information regarding potential developing partnerships or interest related to Mexico’s cannabis legalization has been released, but it is more likely than those deals will begin taking some form in the coming months once the law is set in place.


Investor Takeaway

The news of legalization from a country that has a positive business relationship with Canada should excited investors in the market. The test is now to wait and see which company will launch themselves into the Mexican market.
Don’t forget to follow @INN_LifeScience for real-time updates!
Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

Process leads to standardized psychedelic extracts that are reproducible, scalable, cost-effective and commercially viable

Numinus Wellness Inc. (“Numinus” or the “Company”) (TSXV: NUMI), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, is pleased to announce that its subsidiary Numinus Bioscience Inc. (“Numinus Bioscience”) has filed a provisional patent application with the United States Patent and Trademark Office (USPTO) for a process that dramatically increases the production of therapeutics for use in psychedelic-assisted psychotherapy.

Keep reading... Show less

Opening Marks Company’s 107th Retail Location Nationwide

Strategic Expansion Will Help Serve the State’s Rapidly Growing Cannabis Market

Keep reading... Show less

Ayurcann (CSE:AYUR) entered into a joint venture with Bazelet Group, Israel’s largest privately held medical cannabis company. Ayurcann CEO Igal Sudman shared the company’s excitement about bringing unique terpene-enriched medicinal cannabis to the Canadian marketplace. 

“Canada is a very closed-loop country, and the opportunity to bring a variety of different enhancement and technologically advanced products is very important to us. The relationship that we formed with Bazelet is going to enhance our offerings into the Canadian marketplace,” Sudman said. 

Bazelet has launched multiple lines of terpene-enriched cannabis oils; each one is specifically designed for various indications, symptoms and personal needs. The company’s terpene-enriched products are optimized for women’s health, for elderly population needs, for specific types of pains (muscle, joint, neuropathic) and for improved night sleep. 

According to Sudman, there are a lot of larger companies that have tried to do this, but none have been able to successfully bring innovation into the market. Ayurcann is rapidly forging partnerships with several companies worldwide, including Cannmart, Patient Choice and Kindred Partners.

“We’re growing the business, customer base, relationships and partnerships worldwide. We’re bringing the latest technology into Canada, and enhancing not only our company, but the investors’ value moving forward,” added Sudman. 

Watch the full interview with Ayurcann CEO Igal Sudman above.

Keep reading... Show less

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a new Florida dispensary, the Company’s 91st nationwide.

The latest dispensary, located in Winter Park , supports Trulieve’s goal of ensuring medical cannabis patients across Florida have safe, reliable access to the medications they rely on. The dispensary expands access throughout Central Florida , joining four locations throughout nearby Orlando .

Keep reading... Show less

Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (“Nextleaf”, “OILS”, or the “Company”), the world’s most innovative cannabis extractor, is pleased to announce that the United States Patent and Trademark Office has granted the Company a patent pertaining to the extraction and purification of THC and CBD.

The Company believes it has developed defendable intellectual property around the most efficient methods for producing THC and CBD distillate at scale within a regulated market. Nextleaf owns 15 U.S. patents and has been issued over 80 patents globally.

Keep reading... Show less